Research output per year
Research output per year
Personal profile
Research interests
Suresh Senan is the Professor of Clinical Experimental Radiotherapy at the Amsterdam University Medical Centers (VUmc location), The Netherlands. He completed training in radiotherapy and oncology in the United Kingdom. His research group is active in lung cancer, use of immune checkpoint inhibitors, magnetic resonance imaging-guided radiotherapy and stereotactic radiotherapy. He is a faculty member for thoracic malignancies at the European Society for Medical Oncology.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer
Ronden, M. I., Bahce, I., Hashemi, S. M. S., Dickhoff, C., de Haan, P. F., Becker, A., Spoelstra, F. O. B., Dahele, M. R., Ali, R., Tiemessen, M. A., Tarasevych, S., Maassen van den Brink, K., Haasbeek, C. J. A., Daniels, J. M. A., van Laren, M., Verbakel, W. F. A. R. & Senan, S., 1 Feb 2021, In: Lung Cancer. 152, p. 149-156 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial: Four-year survival with durvalumab after chemoradiotherapy in Stage III NSCLC - an update from the PACIFIC trial
Faivre-Finn, C., Vicente, D., Kurata, T., Planchard, D., Paz-Ares, L., Vansteenkiste, J. F., Spigel, D. R., Garassino, M. C., Reck, M., Senan, S., Naidoo, J., Rimner, A., Wu, Y-L., Gray, J. E., Özgüroğlu, M., Lee, K. H., Cho, B. C., Kato, T., de Wit, M., Newton, M. & 3 others, , 18 Jan 2021, In: Journal of Thoracic Oncology.Research output: Contribution to journal › Article › Academic › peer-review
-
Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)
Faivre-Finn, C., Spigel, D. R., Senan, S., Langer, C., Perez, B. A., Özgüroğlu, M., Daniel, D., Villegas, A., Vicente, D., Hui, R., Murakami, S., Paz-Ares, L., Broadhurst, H., Wadsworth, C., Dennis, P. A. & Antonia, S. J., Jan 2021, In: Lung Cancer. 151, p. 30-38 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Is SABR cost-effective in oligometastatic cancer? An economic analysis of the SABR-COMET randomized trial
Qu, X. M., Chen, Y., Zaric, G. S., Senan, S., Olson, R. A., Harrow, S., John-Baptiste, A., Gaede, S., Mulroy, L. A., Schellenberg, D., Senthi, S., Swaminath, A., Kopek, N., Liu, M., Warner, A., Rodrigues, G. B., Palma, D. A. & Louie, A. V., 1 Apr 2021, In: International journal of radiation oncology, biology, physics. 109, 5, p. 1176-1184 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach
Popat, S., Navani, N., Kerr, K. M., Smit, E. F., Batchelor, T. J. P., van Schil, P., Senan, S. & McDonald, F., 1 Feb 2021, In: The Oncologist. 26, 2, p. e306-e315Research output: Contribution to journal › Article › Academic › peer-review
Open Access